• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vonoprazan in Helicobacter pylori treatment regimens in India: Dawn of a New Era.

作者信息

Jena Anuraag, Dutta Usha

机构信息

Department of Gastroenterology, Institute of Medical Science and SUM Hospital, Bhubaneswar, 751 003, India.

Department of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160 012, India.

出版信息

Indian J Gastroenterol. 2025 Aug;44(4):427-429. doi: 10.1007/s12664-025-01790-8.

DOI:10.1007/s12664-025-01790-8
PMID:40533712
Abstract
摘要

相似文献

1
Vonoprazan in Helicobacter pylori treatment regimens in India: Dawn of a New Era.沃克在印度幽门螺杆菌治疗方案中的应用：新时代的曙光
Indian J Gastroenterol. 2025 Aug;44(4):427-429. doi: 10.1007/s12664-025-01790-8.
2
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.系统评价与荟萃分析：基于沃克奥美拉唑的三联疗法对幽门螺杆菌根除的疗效
Aliment Pharmacol Ther. 2017 Jul;46(2):106-114. doi: 10.1111/apt.14130. Epub 2017 May 12.
3
Fourteen-day vonoprazan-amoxicillin dual therapy versus 14-day bismuth-based quadruple therapy for treatment: a randomized clinical trial.伏诺拉生-阿莫西林14天双重疗法与14天铋剂四联疗法治疗的随机临床试验
Therap Adv Gastroenterol. 2025 Jul 13;18:17562848251354868. doi: 10.1177/17562848251354868. eCollection 2025.
4
First-line Eradication of Helicobacter pylori Infection with High-Dose Amoxicillin and Vonoprazan: A Systematic Review and Meta-analysis.高剂量阿莫西林和沃克帕唑一线根除幽门螺杆菌感染：一项系统评价和荟萃分析
Turk J Gastroenterol. 2025 Jun 16;36(7):410-419. doi: 10.5152/tjg.2025.24371.
5
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.系统评价与荟萃分析：强效酸抑制剂——沃诺拉赞优于质子泵抑制剂，可根除克拉霉素耐药的幽门螺杆菌菌株。
Helicobacter. 2018 Aug;23(4):e12495. doi: 10.1111/hel.12495. Epub 2018 Jun 6.
6
Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial.阿莫西林剂量对伏诺拉生和阿莫西林联合治疗幽门螺杆菌的治愈率、肠道微生物群及抗生素耐药组的影响：一项多中心、开放标签、非劣效性随机对照试验
Lancet Microbe. 2025 Mar;6(3):100975. doi: 10.1016/j.lanmic.2024.100975. Epub 2024 Dec 18.
7
Optimizing Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments.优化治疗：基于经验和药敏试验的治疗方法的最新综述。
Gut Liver. 2023 Sep 15;17(5):684-697. doi: 10.5009/gnl220429. Epub 2023 Feb 27.
8
Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial.沃克改善铋剂四联疗法对幽门螺杆菌补救治疗的疗效：一项多中心随机对照试验
Helicobacter. 2025 Jul-Aug;30(4):e70056. doi: 10.1111/hel.70056.
9
Efficacy and safety of Vonoprazan-based treatment of Helicobacter pylori infection: a systematic review and network meta-analysis.基于 Vonoprazan 的幽门螺杆菌感染治疗的疗效和安全性：系统评价和网络荟萃分析。
BMC Infect Dis. 2024 Sep 11;24(1):953. doi: 10.1186/s12879-024-09885-x.
10
Low-dose or high-dose amoxicillin in vonoprazan-based dual therapy for Helicobacter pylori eradication? A systematic review and meta-analysis.基于 vonoprazan 的双联疗法中低剂量或高剂量阿莫西林用于幽门螺杆菌根除？系统评价和荟萃分析。
Helicobacter. 2024 Jan-Feb;29(1):e13054. doi: 10.1111/hel.13054.

本文引用的文献

1
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南：幽门螺杆菌感染的治疗
Am J Gastroenterol. 2024 Sep 1;119(9):1730-1753. doi: 10.14309/ajg.0000000000002968. Epub 2024 Sep 4.
2
A survey of practice patterns and adherence to national and international guidelines on the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in India.印度胃肠病学家和胃肠病学进修医生中幽门螺杆菌感染管理的实践模式及对国家和国际指南的遵循情况调查。
Indian J Gastroenterol. 2025 Apr;44(2):208-219. doi: 10.1007/s12664-024-01694-z. Epub 2024 Oct 17.
3
Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial.
沃诺拉赞双联或三联疗法与铋四联疗法作为幽门螺杆菌感染一线治疗的比较：一项三臂、随机临床试验。
Helicobacter. 2024 Sep-Oct;29(5):e13133. doi: 10.1111/hel.13133.
4
10-Day versus 14-day bismuth quadruple therapy for first-line eradication of infection: a randomised, open-label, non-inferiority trial.10天与14天铋剂四联疗法用于一线根除幽门螺杆菌感染：一项随机、开放标签、非劣效性试验
EClinicalMedicine. 2024 Mar 11;70:102529. doi: 10.1016/j.eclinm.2024.102529. eCollection 2024 Apr.
5
Vonoprazan: A Review in Helicobacter pylori Infection.沃诺拉赞：治疗幽门螺杆菌感染的药物。
Drugs. 2024 Mar;84(3):319-327. doi: 10.1007/s40265-023-01991-5. Epub 2024 Feb 23.
6
Ten-Day Vonoprazan-Amoxicillin Dual Therapy vs Standard 14-Day Bismuth-Based Quadruple Therapy for First-Line Helicobacter pylori Eradication: A Multicenter Randomized Clinical Trial.十日 Vonoprazan-阿莫西林双联疗法与标准 14 日铋剂四联疗法一线治疗幽门螺杆菌根除：一项多中心随机临床试验。
Am J Gastroenterol. 2024 Apr 1;119(4):655-661. doi: 10.14309/ajg.0000000000002592. Epub 2023 Nov 17.
7
Drug Resistance Patterns of Commonly Used Antibiotics for the Treatment of Infection among South Asian Countries: A Systematic Review and Meta-Analysis.南亚国家治疗感染常用抗生素的耐药模式：系统评价与荟萃分析
Trop Med Infect Dis. 2023 Mar 14;8(3):172. doi: 10.3390/tropicalmed8030172.
8
Cost-Effectiveness of Vonoprazan-Based and Rifabutin-Based vs Other Regimens as First-Line Treatment of Helicobacter pylori Infection in the United States.在美国，基于沃克帕唑和利福布汀的方案与其他方案作为幽门螺杆菌感染一线治疗的成本效益比较
Am J Gastroenterol. 2023 Apr 1;118(4):635-644. doi: 10.14309/ajg.0000000000002146. Epub 2022 Dec 14.
9
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.Vonoprazan 三联和双联疗法治疗美国和欧洲的幽门螺杆菌感染：随机临床试验。
Gastroenterology. 2022 Sep;163(3):608-619. doi: 10.1053/j.gastro.2022.05.055. Epub 2022 Jun 6.
10
Low clarithromycin resistance in virulent Helicobacter pylori from dyspeptic patients at a tertiary care centre in Odisha.奥里萨邦一家三级护理中心消化不良患者中致病性幽门螺杆菌对克拉霉素的低耐药性
Indian J Med Microbiol. 2022 Apr-Jun;40(2):211-216. doi: 10.1016/j.ijmmb.2022.02.008. Epub 2022 Mar 26.